Letter withdrawing Cisapride (Prepulsid) from the UK.

Information from the RxList.

New Zealand government safety bulletin.

Information on dosage, usage, side effects, interactions, and drug comparisons.

Notification of important changes in the U.S. FDA Propulsid labeling to reflect new safety information, including recommendations for performing diagnostics tests prior to any use.

A Medical Position Statement of the North American Society for Pediatric Gastroenterology and Nutrition. Discusses the risks and benefits of this medication for treating gastroesophageal reflux and other conditions.